Literature DB >> 28107024

The Host Response in Patients with Sepsis Developing Intensive Care Unit-acquired Secondary Infections.

Lonneke A van Vught1,2, Maryse A Wiewel1,2, Arie J Hoogendijk1,2, Jos F Frencken3,4, Brendon P Scicluna1,2,5, Peter M C Klein Klouwenberg3,4,6, Aeilko H Zwinderman5, Rene Lutter7, Janneke Horn8, Marcus J Schultz8, Marc M J Bonten3,6, Olaf L Cremer4, Tom van der Poll1,2,9.   

Abstract

RATIONALE: Sepsis can be complicated by secondary infections. We explored the possibility that patients with sepsis developing a secondary infection while in the intensive care unit (ICU) display sustained inflammatory, vascular, and procoagulant responses.
OBJECTIVES: To compare systemic proinflammatory host responses in patients with sepsis who acquire a new infection with those who do not.
METHODS: Consecutive patients with sepsis with a length of ICU stay greater than 48 hours were prospectively analyzed for the development of ICU-acquired infections. Twenty host response biomarkers reflective of key pathways implicated in sepsis pathogenesis were measured during the first 4 days after ICU admission and at the day of an ICU-acquired infection or noninfectious complication.
MEASUREMENTS AND MAIN RESULTS: Of 1,237 admissions for sepsis (1,089 patients), 178 (14.4%) admissions were complicated by ICU-acquired infections (at Day 10 [6-13], median with interquartile range). Patients who developed a secondary infection showed higher disease severity scores and higher mortality up to 1 year than those who did not. Analyses of biomarkers in patients who later went on to develop secondary infections revealed a more dysregulated host response during the first 4 days after admission, as reflected by enhanced inflammation, stronger endothelial cell activation, a more disturbed vascular integrity, and evidence for enhanced coagulation activation. Host response reactions were similar at the time of ICU-acquired infectious or noninfectious complications.
CONCLUSIONS: Patients with sepsis who developed an ICU-acquired infection showed a more dysregulated proinflammatory and vascular host response during the first 4 days of ICU admission than those who did not develop a secondary infection.

Entities:  

Keywords:  ICU-acquired infection; biomarker; host response; intensive care unit; sepsis

Mesh:

Substances:

Year:  2017        PMID: 28107024     DOI: 10.1164/rccm.201606-1225OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  30 in total

1.  A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.

Authors:  Valerie Cuvier; Ulrike Lorch; Stephan Witte; Aurelie Olivier; Sebastien Gibot; Isabelle Delor; Jean-Jacques Garaud; Marc Derive; Margarita Salcedo-Magguilli
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

2.  A Biosignature Predicting Complicated Course in Children Presenting with Septic Shock. Why PERSEVERE?

Authors:  Adrienne G Randolph
Journal:  Am J Respir Crit Care Med       Date:  2017-08-15       Impact factor: 21.405

3.  Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses.

Authors:  Kaori Oshima; Xiaorui Han; Yilan Ouyang; Rana El Masri; Yimu Yang; Sarah M Haeger; Sarah A McMurtry; Trevor C Lane; Pavel Davizon-Castillo; Fuming Zhang; Xinping Yue; Romain R Vivès; Robert J Linhardt; Eric P Schmidt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-28       Impact factor: 5.464

4.  A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score.

Authors:  Jan-Alexis Tremblay; Florian Peron; Louis Kreitmann; Julien Textoris; Karen Brengel-Pesce; Anne-Claire Lukaszewicz; Laurence Quemeneur; Christophe Vedrine; Lionel K Tan; Fabienne Venet; Thomas Rimmele; Guillaume Monneret
Journal:  Ann Intensive Care       Date:  2022-08-17       Impact factor: 10.318

5.  Pattern of tamoxifen-induced Tie2 deletion in endothelial cells in mature blood vessels using endo SCL-Cre-ERT transgenic mice.

Authors:  Peter J Zwiers; Rianne M Jongman; Timara Kuiper; Jill Moser; Radu V Stan; Joachim R Göthert; Matijs van Meurs; Eliane R Popa; Grietje Molema
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

6.  Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation.

Authors:  Tom D Y Reijnders; Hessel Peters-Sengers; Lonneke A van Vught; Fabrice Uhel; Marc J M Bonten; Olaf L Cremer; Marcus J Schultz; Martijn M Stuiver; Tom van der Poll
Journal:  Crit Care       Date:  2022-05-24       Impact factor: 19.334

Review 7.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

8.  Mycophenolate Mofetil Protects Septic Mice via the Dual Inhibition of Inflammatory Cytokines and PD-1.

Authors:  Shun-Wei Huang; Hao Chen; Mei-Ling Lu; Jin-Long Wang; Rong-Li Xie; Bing Zhao; Ying Chen; Zhi-Wei Xu; Jian Fei; En-Qiang Mao; Er-Zhen Chen
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

9.  Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study.

Authors:  Eduarda Cristina Martins; Lilian da Fe Silveira; Karin Viegas; Andrea Diez Beck; Geferson Fioravantti Júnior; Rafael Viegas Cremonese; Priscila Schmidt Lora
Journal:  Rev Bras Ter Intensiva       Date:  2019-03-21

10.  Low Serum Angiopoietin-1, High Serum Angiopoietin-2, and High Ang-2/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns.

Authors:  Rens Zonneveld; Rianne Jongman; Amadu Juliana; Wilco Zijlmans; Frans Plötz; Grietje Molema; Matijs van Meurs
Journal:  Shock       Date:  2017-12       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.